5-[¹²⁵I]IODO-2'-Deoxyuridine in the Radiotherapy of Solid CNS Tumors in Rats

References

• Charlton D. E., Booz J. A Monte Carlo treatment of the decay of 125I. Radiat Res 1981; 87: 10–23
   PubMed Web of Science ®Google Scholar
• Sastry K. S. R., Rao D. V. Dosimetry of low energy electrons. Physics of nuclear medicine: recent advances, American Association of Physicists in Medicine, Medical Physics Monograph No 10, D. V. Rao, R. Chandra, M. C. Graham. American Institute of Physics, Woodbury, New York 1984; 169–208
   Google Scholar
• Kassis A. I., Sastry K. S. R., Adelstein S. J. Intracellular localisation of Auger electron emitters: biophysical dosimetry. Radiat Prot Dosim 1985; 13: 233–6
   Web of Science ®Google Scholar
• Kassis A. I., Sastry K. S. R., Adelstein S. J. Kinetics of uptake, retention, and radiotoxicity of 125IUdR in mammalian cells: implications of localized energy deposition by Auger processes. Radiat Res 1987; 109: 78–89
   PubMed Web of Science ®Google Scholar
• Kassis A. I., Fayad F., Kinsey B. M., Sastry K. S. R., Taube R. A., Adelstein S. J. Radiotoxicity of 125I in mammalian cells. Radiat Res 1987; 111: 305–18
   PubMed Web of Science ®Google Scholar
• Charlton D. E., Humm J. L. A method of calculating initial DNA strand breakage following the decay of incorporated 125I. Int J Radiat Biol 1988; 53: 353–65
   Web of Science ®Google Scholar
• Hofer K. G., Hughes W. L. Radiotoxicity of intracellular tritium 125iodine and 131iodine. Radiat Res 1971; 47: 94–109
   PubMed Web of Science ®Google Scholar
• Bradley E. W., Chan P. C., Adelstein S. J. The radiotoxicity of iodine-125 in mammalian cells. I. Effects on the survival curve of radioiodine incorporated into DNA. Radiat Res 1975; 64: 555–63
   Google Scholar
• Chan P. C., Lisco E., Lisco H., Adelstein S. J. The radiotoxicity of iodine-125 in mammalian cells. II. A comparative study on cell survival and cytogenetic responses to 125IUdR, 131IUdR, and 3HTdR. Radiat Res 1976; 67: 332–43
   PubMed Web of Science ®Google Scholar
• Hofer K. G., Harris C. R., Smith J. M. Radiotoxicity of intracellular 67Ga 125I and 3H. Nuclear versus cytoplasmic radiation effects in murine L1210 leukaemia. Int J Radiat Biol 1975; 28: 225–41
   Web of Science ®Google Scholar
• Warters R. L., Hofer K. G., Harris C. R., Smith J. M. Radionuclide toxicity in cultured mammalian cells: elucidation of the primary site of radiation damage. Curr Top Radiat Res Q 1977; 12: 389–407
   Google Scholar
• Mariani G., Cei A., Giuliani L., et al. Tumor targeting potential and metabolism of 5[125I]iodo-2'-deoxyuridine injected intratumorally in patients with gastrointestinal or breast cancers. J Nucl Biol Med 1992; 36: 154–7
   Google Scholar
• Mariani G., Cei A., Collecchi P., et al. Tumor targeting in vivo and metabolic fate of 5-[iodine-125]iodo-2'-deoxyuridine following intratumoral injection in patients with colorectal cancer. J Nucl Med 1993; 34: 1175–83
   PubMed Web of Science ®Google Scholar
• Kassis Al, Van den Abbeele A. D., Wen P. Y. C., et al. Specific uptake of the Auger electron-emitting thymidine analogue 5-[123I/125I]iodo-2'-deoxyuridine in rat brain tumors: diagnostic and therapeutic implications in humans. Cancer Res 1990; 50: 5199–203
   PubMed Web of Science ®Google Scholar
• Baranowska-Kortylewicz J., Makrigiorgos G. M., Van den Abbeele A. D., Berman R. M., Adelstein S. J., Kassis A. I. 5-[123I]iodo-2'-deoxyuridine in the radiotherapy of an early ascites tumor model. Int J Radiat Oncol Biol Phys 1991; 21: 1541–51
   PubMed Web of Science ®Google Scholar
• Van den Abbeele A. D., Tutrone R. F., Berman R. M., et al. Tumor-targeting potential of radioiodinated iododeoxyuridine in bladder cancer. J Nucl Med 1996; 37: 315–20
   PubMed Web of Science ®Google Scholar
• Mariani G., Di Sacco G., Matteucci F., et al. Intra-arterial infusion of 5-[123I]iodo-2'-deoxyuridine in patients with liver metastases from colon cancer. J Nucl Biol Med 1993; 37: 157–8
   Google Scholar
• Bloomer W. D., Adelstein S. J. 5-125I-iododeoxyuridine as prototype for radionuclide therapy with Auger emitters. Nature 1977; 265: 620–1
   PubMed Web of Science ®Google Scholar
• Baranowska-Kortylewicz J., Kinsey B. M., Layne W. W., Kassis A. I. Radioiododemercuration: a simple synthesis of 5-[123/125/125I]iodo-2'-deoxyuridine. Appl Radiat Isot 1988; 39: 335–41
   Web of Science ®Google Scholar
• Foulon C. F., Zhang Y. Z., Adelstein S. J., Kassis A. I. Instantaneous preparation of radiolabeled 5-iodo-2'-deoxyuridine. Appl Radiat Isot 1995; 46: 1039–46
   PubMed Web of Science ®Google Scholar
• Kooistra K. L., Rodriguez M., Powis G., et al. Development of experimental models for meningeal neoplasia using intrathecal injection of 9L gliosarcoma and Walker 256 carcinosarcoma in the rat. Cancer Res 1986; 46: 317–23
   PubMed Web of Science ®Google Scholar
• Hofer K. G., Prensky W., Hughes W. L. Death and metastatic distribution of tumor cells in mice monitored with 125I-iododeoxy-uridine. J Natl Cancer Inst 1969; 43: 763–73
   PubMedGoogle Scholar
• Le Mevel B. P., Oldham R. K., Wells S. A., Herberman R. B. An evaluation of 125I-iododeoxyuridine as a cellular label for in-vitro assays: kinetics of incorporation and toxicity. J Natl Cancer Inst 1973; 51: 1551–8
   PubMedGoogle Scholar
• Commerford S. L., Joel D. D. Iododeoxyuridine administered to mice isde-iodinated and incorporated into DNA primarily as thymidylate. Biochem Biophys Res Commun 1979; 86: 112–8
   PubMed Web of Science ®Google Scholar
• Garrett C., Wataya Y., Santi D. V. Thymidylate synthetase. Catalysis of dehalogenation of 5-bromo- and 5-iodo-2'-de-oxyuridylate. Biochemistry 1979; 18: 2798–804
   PubMed Web of Science ®Google Scholar
• Clarkson D. R., Oppelt W. W., Byvoet P. The fate of 5-iodo-2'-deoxyuridine (IUdR) in plasma and cerebrospinal fluid of dogs. J Pharmacol Exp Ther 1967; 157: 581–8
   PubMed Web of Science ®Google Scholar
• Paulsen O. Uptake of 5(125I) iodo-2-deoxyuridine (IDU) in plasma and cerebrospinal fluid in a case of herpes encephalitis with a comparative study on the uptake in plasma cerebrospinal fluid and brain tissue in dogs. Scand J Infect Dis 1977; 9: 85–9
   PubMed Web of Science ®Google Scholar